Grant Street Asset Management’s AbbVie ABBV Stock Holding History

Grant Street Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$906K	Sell	3,600 -296	-8%	-$63.7K	0.15%	38
2026 Q1	$847K	Sell	3,896 -96	-2%	-$21.3K	0.16%	36
2025 Q4	$912K	Sell	3,992 -505	-11%	-$115K	0.18%	32
2025 Q3	$1.04M	Sell	4,497 -25	-0.6%	-$5.09K	0.22%	29
2025 Q2	$839K	Buy	4,522 +144	+3%	+$26.8K	0.19%	30
2025 Q1	$917K	Sell	4,378 -1,420	-24%	-$276K	0.22%	29
2024 Q4	$1.03M	Buy	5,798 +2,247	+63%	+$413K	0.27%	30
2024 Q3	$701K	Buy	3,551 +20	+0.6%	+$3.73K	0.21%	33
2024 Q2	$606K	Hold	3,531	–	–	0.19%	35
2024 Q1	$643K	Buy	3,531 +2	+0.1%	+$345	0.21%	32
2023 Q4	$547K	Buy	3,529 +30	+0.9%	+$4.37K	0.19%	32
2023 Q3	$522K	Sell	3,499 -71	-2%	-$10.4K	0.21%	31
2023 Q2	$481K	Buy	3,570 +54	+2%	+$7.92K	0.18%	34
2023 Q1	$560K	Hold	3,516	–	–	0.23%	29
2022 Q4	$568K	Hold	3,516	–	–	0.25%	28
2022 Q3	$472K	Hold	3,516	–	–	0.21%	33
2022 Q2	$538K	Buy	3,516 +1,148	+48%	+$175K	0.28%	31
2022 Q1	$384K	Sell	2,368 -400	-14%	-$58.1K	0.21%	28
2021 Q4	$375K	Buy	2,768 +400	+17%	+$47.3K	0.2%	27
2021 Q3	$255K	Hold	2,368	–	–	0.15%	31
2021 Q2	$267K	Sell	2,368 -103	-4%	-$11.6K	0.16%	30
2021 Q1	$267K	Hold	2,471	–	–	0.15%	32
2020 Q4	$265K	Hold	2,471	–	–	0.14%	26
2020 Q3	$216K	Hold	2,471	–	–	0.13%	30
2020 Q2	$243K	Buy	+2,471	New	+$218K	0.14%	25

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Grant Street Asset Management's ABBV Position: Q2 2026 in Review

Grant Street Asset Management reduced its AbbVie (ABBV) stake by 7.6% in Q2 2026, selling an estimated $63.7K and leaving 3,600 shares worth $906K. The position accounts for 0.15% of the portfolio, ranked #38.

Grant Street Asset Management first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.04M in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Grant Street Asset Management held 3,600 shares of AbbVie worth $906K as of Q2 2026.
Grant Street Asset Management sold 296 AbbVie shares in Q2 2026, an estimated $63.7K.
AbbVie made up 0.15% of Grant Street Asset Management's portfolio in Q2 2026, its #38 holding.
Grant Street Asset Management first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
Grant Street Asset Management's AbbVie position peaked at $1.04M in Q3 2025.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Grant Street Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.